Home > Balance Sheet > SYNCOM FORMULATIONS (INDIA)

SYNCOM FORMULATIONS (INDIA)
Net Current Assets

    Back to Balance Sheet
SYNCOM FORMULATIONS (INDIA) is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for SYNCOM FORMULATIONS (INDIA)
Please provide your vote to see the results

SYNCOM FORMULATIONS (INDIA) Last 5 Year Net Current Assets History

[Consolidated]

Mar2024Mar2023Mar2022Mar2017Mar2016
Net Current Assets (Including Current Investments) ₹168 Cr₹69 Cr₹62 Cr₹28 Cr₹26 Cr

What is the latest Net Current Assets ratio of SYNCOM FORMULATIONS (INDIA) ?

The latest Net Current Assets ratio of SYNCOM FORMULATIONS (INDIA) is ₹168 Cr based on Mar2024 Consolidated results.
Year Net Current Assets
Mar2024₹168 Cr
Mar2023₹69 Cr
Mar2022₹62 Cr
Mar2017₹28 Cr
Mar2016₹26 Cr

How is Net Current Assets of SYNCOM FORMULATIONS (INDIA) Trending?

Years Net Current Assets % Change
Mar2024 ₹168 Cr
145.53
Mar2023 ₹69 Cr
11.35
Mar2022 ₹62 Cr
122.16
Mar2017 ₹28 Cr
6.65
Mar2016 ₹26 Cr -

Compare Net Current Assets of peers of SYNCOM FORMULATIONS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA) ₹2,070.8 Cr 5.8% 34% 85.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹405,068.0 Cr 1.4% 0.1% 13.9% Stock Analytics
DIVIS LABORATORIES ₹177,105.0 Cr 0.8% 12.3% 47.2% Stock Analytics
CIPLA ₹122,016.0 Cr 2.6% -0.1% 0.6% Stock Analytics
DR REDDYS LABORATORIES ₹112,651.0 Cr 7.8% 12.9% 13.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹108,942.0 Cr 2.7% -0.6% 14.4% Stock Analytics


SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA)

5.8%

34%

85.5%

SENSEX

2.1%

3.7%

14.3%


You may also like the below Video Courses